{"id":"placebo-ethinylestradiol-levonorgestrel","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5-15","effect":"Breakthrough bleeding"},{"rate":"5","effect":"Mood changes"},{"rate":"0.3-0.4","effect":"Venous thromboembolism"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ethinylestradiol is a synthetic estrogen and levonorgestrel is a synthetic progestin. Together they suppress the luteinizing hormone (LH) and follicle-stimulating hormone (FSH) surges needed for ovulation. The progestin component also increases cervical mucus viscosity to impede sperm transport. The placebo tablets in the pack contain no active ingredients and allow for withdrawal bleeding during the hormone-free interval.","oneSentence":"Ethinylestradiol and levonorgestrel work together as a combined oral contraceptive to prevent ovulation and thicken cervical mucus, thereby preventing pregnancy.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:45.802Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception / prevention of pregnancy"}]},"trialDetails":[{"nctId":"NCT04255277","phase":"PHASE1","title":"To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2020-01-31","conditions":"Healthy Subjects","enrollment":97},{"nctId":"NCT05058872","phase":"PHASE4","title":"Contraceptive Hormone and Reward Measurement (CHARM Study)","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2021-10-01","conditions":"Oral Hormonal Contraceptive Use, Neural Activity, Mood","enrollment":144},{"nctId":"NCT05487092","phase":"NA","title":"Letrozole in Preventing Recurrence of Endometrioma Following Laparoscopic Ovarian Cystectomy","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2022-12-01","conditions":"Endometriotic Cyst of Ovary","enrollment":194},{"nctId":"NCT03745144","phase":"PHASE1","title":"Effects of Cladribine Tablets on the PK of Microgynon®","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2019-01-17","conditions":"Relapsing Multiple Sclerosis (RMS)","enrollment":28},{"nctId":"NCT05212389","phase":"NA","title":"The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2021-12-22","conditions":"Major Depressive Disorder, Sexual Behavior, Mood Disturbance","enrollment":40},{"nctId":"NCT02085863","phase":"PHASE1","title":"A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-02","conditions":"Pharmacokinetics, Pharmacodynamics","enrollment":40},{"nctId":"NCT02002260","phase":"NA","title":"Stopping Heavy Periods Project","status":"UNKNOWN","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2013-02","conditions":"Abnormal Uterine Bleeding, Abnormal Uterine Bleeding, Ovulatory Dysfunction, Abnormal Uterine Bleeding, Endometrial Hemostatic Dysfunction","enrollment":59},{"nctId":"NCT00662454","phase":"PHASE4","title":"Oral Contraceptive Efficacy and Body Weight","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2006-01","conditions":"Contraception, Body Weight","enrollment":120},{"nctId":"NCT04142762","phase":"PHASE1","title":"A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults","status":"COMPLETED","sponsor":"Assembly Biosciences","startDate":"2019-10-18","conditions":"Chronic Hepatitis B","enrollment":80},{"nctId":"NCT02362711","phase":"PHASE3","title":"Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2015-02","conditions":"Dysmenorrhea","enrollment":248},{"nctId":"NCT03210246","phase":"PHASE1","title":"Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-07-17","conditions":"Clinical Trial ,Phase I","enrollment":71},{"nctId":"NCT02846142","phase":"PHASE1","title":"Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers","status":"COMPLETED","sponsor":"Proteostasis Therapeutics, Inc.","startDate":"2016-06","conditions":"Healthy Volunteer","enrollment":94},{"nctId":"NCT00310791","phase":"PHASE2, PHASE3","title":"Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2004-04","conditions":"Anorexia Nervosa","enrollment":80},{"nctId":"NCT02957630","phase":"PHASE1, PHASE2","title":"\"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study\"","status":"COMPLETED","sponsor":"Estetra","startDate":"2016-09","conditions":"Contraception, Liver Metabolism, Hemostasis Parameter","enrollment":101},{"nctId":"NCT03359057","phase":"PHASE3","title":"Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel","status":"COMPLETED","sponsor":"Galeno Desenvolvimento de Pesquisas Clínicas","startDate":"2013-02-26","conditions":"Contraception","enrollment":36},{"nctId":"NCT01963403","phase":"PHASE4","title":"Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive","status":"TERMINATED","sponsor":"University of California, Davis","startDate":"2013-12","conditions":"Abnormal Uterine Bleeding, Unspecified, Uterine Bleeding Heavy","enrollment":26},{"nctId":"NCT01324505","phase":"PHASE1","title":"Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2011-03","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":43},{"nctId":"NCT00781456","phase":"PHASE2","title":"A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2009-01","conditions":"Migraine","enrollment":109},{"nctId":"NCT01508858","phase":"PHASE1","title":"Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":21},{"nctId":"NCT01615354","phase":"PHASE1","title":"A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2012-07","conditions":"Healthy Volunteer","enrollment":18},{"nctId":"NCT02475564","phase":"PHASE4","title":"Resveratrol for Pain Due to Endometriosis","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2015-06","conditions":"Endometriosis","enrollment":44},{"nctId":"NCT00196313","phase":"PHASE2","title":"A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2005-05","conditions":"Dysmenorrhea","enrollment":95},{"nctId":"NCT01968135","phase":"PHASE2","title":"Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2013-10","conditions":"Uterine Hemorrhage, Contraception","enrollment":32},{"nctId":"NCT00778609","phase":"PHASE3","title":"Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-12","conditions":"Oral Contraceptive, Headache, Pelvic Pain","enrollment":449},{"nctId":"NCT00920985","phase":"PHASE3","title":"US Cycle Control and Blood Pressure Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-06","conditions":"Contraception","enrollment":346},{"nctId":"NCT00909857","phase":"PHASE3","title":"Effect on Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-04","conditions":"Primary Dysmenorrhea","enrollment":507},{"nctId":"NCT00764881","phase":"PHASE3","title":"Effects of SH T00658ID on Libido","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-01","conditions":"Contraception, Libido","enrollment":217},{"nctId":"NCT00480532","phase":"NA","title":"A Study of Continuous Oral Contraceptives and Doxycycline","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2007-05","conditions":"Contraceptives, Oral","enrollment":131},{"nctId":"NCT00924560","phase":"PHASE2","title":"A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2009-06","conditions":"Bone Mineral Density","enrollment":1361},{"nctId":"NCT02257671","phase":"NA","title":"Oral Contraceptives and Economic Behaviour","status":"UNKNOWN","sponsor":"Karolinska University Hospital","startDate":"2012-02","conditions":"Female Contraception","enrollment":400},{"nctId":"NCT00196365","phase":"PHASE3","title":"A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2005-01","conditions":"Dysmenorrhea","enrollment":97},{"nctId":"NCT00318799","phase":"PHASE2","title":"Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-04","conditions":"Pregnancy, Unplanned","enrollment":29},{"nctId":"NCT00117260","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density","status":"WITHDRAWN","sponsor":"Duramed Research","startDate":"2005-07","conditions":"Osteopenia","enrollment":""},{"nctId":"NCT00394771","phase":"PHASE2","title":"A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2006-10","conditions":"Breakthrough Bleeding","enrollment":567},{"nctId":"NCT01297179","phase":"PHASE1","title":"A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2008-10","conditions":"Healthy Volunteers, Pharmacokinetics of Mirabegron","enrollment":30},{"nctId":"NCT01569113","phase":"PHASE4","title":"Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.","status":"COMPLETED","sponsor":"HRA Pharma","startDate":"2012-03","conditions":"Emergency Contraception","enrollment":76},{"nctId":"NCT00161681","phase":"PHASE3","title":"Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-07","conditions":"Premenstrual Syndrome","enrollment":200},{"nctId":"NCT00185367","phase":"PHASE3","title":"Comparative Cycle Control Europe","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-03","conditions":"Contraception","enrollment":798},{"nctId":"NCT00185224","phase":"PHASE2","title":"Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-03","conditions":"Contraception","enrollment":58},{"nctId":"NCT00128934","phase":"PHASE3","title":"Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-08","conditions":"Menstruation Disturbances, Premenstrual Syndrome","enrollment":744},{"nctId":"NCT00195559","phase":"PHASE3","title":"Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-09","conditions":"Premenstrual Syndrome, Menstruation Disturbances","enrollment":526}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Microgynon 30"],"phase":"marketed","status":"active","brandName":"placebo + ethinylestradiol/levonorgestrel","genericName":"placebo + ethinylestradiol/levonorgestrel","companyName":"HRA Pharma","companyId":"hra-pharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ethinylestradiol and levonorgestrel work together as a combined oral contraceptive to prevent ovulation and thicken cervical mucus, thereby preventing pregnancy. Used for Contraception / prevention of pregnancy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}